Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

Drs Carbray and Phelps
Videos
04/09/2024

Featuring Julie Carbray, PhD, and Jim Phelps, MD 

Featuring Julie Carbray, PhD, and Jim...
Join Drs Phelps Carbray in an insightful discussion on the complexities of diagnosing and treating mood disorders and delve into their strategies for unraveling these diagnostic dilemmas and crafting informed treatment plans.
Join Drs Phelps Carbray in an insightful discussion on the complexities of diagnosing and treating mood disorders and delve into their strategies for unraveling these diagnostic dilemmas and crafting informed treatment plans.
Join Drs Phelps Carbray in an...
04/09/2024
Psych Congress Network
rx summit
News
04/09/2024
Jolynn Tumolo
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for people with SUD demonstrate efficacy, but they continue to encounter social stigma and barriers, according to a poster presentation at the RX and Illicit Drug Summit.
Harm reduction services for...
04/09/2024
Psychiatry & Behavioral Health
fda
News
04/08/2024
Meagan Thistle
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for acute schizophrenia treatment, received FDA approval on Friday for acute treatment of manic or mixed episodes associated with bipolar I in adults.
Ilperidone, already approved for...
04/08/2024
Psych Congress Network
two animated heads in profile
News
04/05/2024
Brionna Mendoza
Blonanserin, a novel atypical antipsychotic marketed under the brand name Lonasen, has demonstrated efficacy for improving social functioning in individuals with first-episode schizophrenia.
Blonanserin, a novel atypical antipsychotic marketed under the brand name Lonasen, has demonstrated efficacy for improving social functioning in individuals with first-episode schizophrenia.
Blonanserin, a novel atypical...
04/05/2024
Psych Congress Network
Drs Carbray and Phelps
Videos
04/04/2024

Featuring Julie Carbray, PhD, and Jim Phelps, MD 

Featuring Julie Carbray, PhD, and Jim...
Unlock the intricacies of bipolar disorder diagnosis and what the DSM-5 says with experts Julie Carbray, PhD, and Jim Phelps, MD, in this insightful discussion.
Unlock the intricacies of bipolar disorder diagnosis and what the DSM-5 says with experts Julie Carbray, PhD, and Jim Phelps, MD, in this insightful discussion.
Unlock the intricacies of...
04/04/2024
Psych Congress Network
Client at Pharmacy
News
04/02/2024
Jolynn Tumolo
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance...
04/02/2024
Psychiatry & Behavioral Health
Adults With ADHD Report Camouflaging Their Symptoms
News
04/01/2024
Jolynn Tumolo
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or use strategies to minimize the visibility of symptoms, less than adults with autism but more than age and sex-matched peers without either diagnosis, according to study results published in the journal Autism...
Adults with ADHD camouflage, or...
04/01/2024
Psych Congress Network
A Black infant with bantu knots holds an alphabet letter block
News
04/01/2024
Jolynn Tumolo
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words...
04/01/2024
Psych Congress Network
John Grant, MD
Your Questions Answered
03/28/2024

Featuring John Grant, MD

Featuring John Grant, MD
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores...
03/28/2024
Psych Congress Network
Patients With First-Episode Psychosis Found to Have Cognitive Impairment Before Medication Use
News
03/26/2024
Evi Arthur
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode psychosis (FEP) were found to have cognitive impairment prior to their first use of antipsychotic medications, particularly with large effect sizes, according to recent meta-analysis results published in JAMA...
Patients with first-episode...
03/26/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement